Scarica l'app Stockscreener
318.25
1.16%
4.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$314.14
Aprire:
$313.7
Volume 24 ore:
474.78K
Relative Volume:
0.37
Capitalizzazione di mercato:
$61.86B
Reddito:
$325.78B
Utile/perdita netta:
$1.64B
Rapporto P/E:
38.28
EPS:
8.3139
Flusso di cassa netto:
$3.61B
1 W Prestazione:
-2.24%
1M Prestazione:
-14.60%
6M Prestazione:
+1.93%
1 anno Prestazione:
+14.56%
Intervallo 1D:
$313.22
$318.50
Intervallo di 1 settimana:
$308.48
$326.29
Portata 52W:
$267.40
$377.54
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
318.00 | 61.11B | 325.78B | 1.64B | 3.61B | 8.3139 |
MCK
Mckesson Corporation
|
875.00 | 106.00B | 397.96B | 4.55B | 9.64B | 34.77 |
CAH
Cardinal Health Inc
|
212.90 | 49.72B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
74.42 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.29 | 1.95B | 14.85M | -136.07M | 7.23M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Nisa Investment Advisors LLC Acquires 27,857 Shares of Cencora, Inc. $COR - MarketBeat
Bourgeon Capital Management LLC Invests $2.74 Million in Cencora, Inc. $COR - MarketBeat
Cencora Inc. stock rises Tuesday, still underperforms market - MarketWatch
Spire Wealth Management Raises Stock Position in Cencora, Inc. $COR - MarketBeat
Allspring Global Investments Holdings LLC Sells 40,638 Shares of Cencora, Inc. $COR - MarketBeat
Deals tracker: PE firm acquires Florida physician group - Modern Healthcare
Assessing Cencora (COR) Valuation After Recent Share Price Weakness And Premium P/E Ratio - simplywall.st
Cencora, Inc. (COR) Signs Binding Agreement to Expand Retina Network With EyeSouth Acquisition - Insider Monkey
Donaldson Capital Management LLC Has $46.31 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Cencora, Inc. $COR Shares Sold by Waycross Partners LLC - MarketBeat
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
6,960 Shares in Cencora, Inc. $COR Acquired by Global X Japan Co. Ltd. - MarketBeat
Matrix Trust Co Invests $1.40 Million in Cencora, Inc. $COR - MarketBeat
Synergy Asset Management LLC Cuts Stake in Cencora, Inc. $COR - MarketBeat
Vanguard discloses zero Cencora holdings (NYSE: COR) after internal realignment - Stock Titan
Cencora Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Cencora to buy EyeSouth Partners' retina division in $1B deal - Eyes On Eyecare
Centene Corp stock faces Medicaid managed care pressures amid management uncertainty - AD HOC NEWS
Cencora Inc. stock faces uncertainty amid Medicaid managed care pressures and management shifts - AD HOC NEWS
Cencora (NYSE:COR) Advances Retina Focused Specialty Care Strategy Within S&P 500 - Kalkine Media
Pensionfund Sabic Makes New Investment in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Cencora, Inc. $COR Shares Sold by Avanza Fonder AB - MarketBeat
Cencora Expands Retina Network With EyeSouth Deal And Earnings Focus - simplywall.st
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora to buy EyeSouth’s retina business for $1.1B - Healthcare Dive
COR to Broaden Retina Consultants of America Through $1.1B EyeSouth Acquisition - Bitget
UBS reiterates Cencora stock rating on EyeSouth retina deal - Investing.com
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal - Yahoo Finance Singapore
Cencora to Acquire EyeSouth Partners for $1.1B - citybiz
Kultura Brands (OTC:LTNC) Accelerates National Momentum With Cencora Marketplace Spring & Summer Growth Acceleration Program - The Batesville Daily Guard
Kultura pushes Thirst Responder into U.S. pharmacies for April buying season - Stock Titan
Cencora to buy EyeSouth Partners’ retina business (COR:NYSE) - Seeking Alpha
Cencora, Inc. $COR Shares Bought by SG Americas Securities LLC - MarketBeat
Diversified Trust Co. Sells 9,560 Shares of Cencora, Inc. $COR - MarketBeat
Cencora to acquire EyeSouth Partners retina unit for $1.1 billion By Investing.com - Investing.com Australia
Olympus to Sell Retina Business of EyeSouth Partners to Cencora for $1.1 Billion - VisionMonday.com
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Evercore ISI reiterates Cencora stock rating on retina platform deal By Investing.com - Investing.com India
BofA reiterates Cencora stock rating on retina business expansion By Investing.com - Investing.com Australia
Cencora to Acquire EyeSouth Partners’ Retina Business for $1.1 Billion to Expand Retina Consultants of America - Minichart
Cencora, Inc. (COR) Announces Acquisition of EyeSouth Partners' Retina Business - GuruFocus
Evercore ISI reiterates Cencora stock rating on retina platform deal - Investing.com
BofA reiterates Cencora stock rating on retina business expansion - Investing.com
Cencora buys EyeSouth's retina business in $1.1 billion deal - Reuters
Cencora to Acquire EyeSouth Retina Business for Expansion - TipRanks
Cencora To Acquire EyeSouth Retina Business For $1.1B - citybiz
Cencora to Acquire EyeSouth Partners’ Retina Business for $1.1B, Slightly Accretive to EPS - TradingView
Cencora (NYSE: COR) to acquire EyeSouth retina business in $1.1B deal - Stock Titan
Cencora to acquire EyeSouth Partners retina unit for $1.1 billion - Investing.com
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):